Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • DroneShield Boosts Defence Capability with $13 Million Adelaide R&D Investment
    DroneShield Boosts Defence Capability with $13 Million Adelaide R&D Investment
    • News

  • Stakk Secures T-Mobile Contract to Power Super App Expansion
    Stakk Secures T-Mobile Contract to Power Super App Expansion
    • News

  • Medibank Backs Emyria with Landmark Depression Care Deal
    Medibank Backs Emyria with Landmark Depression Care Deal
    • News

  • NoviqTech Launches Quantum Intelligence Products, Opening Path to Enterprise-Grade Quantum AI
    NoviqTech Launches Quantum Intelligence Products, Opening Path to Enterprise-Grade Quantum AI
    • News

  • BRE Wins Final Permit to Advance Rare Earth Pilot Plant in Brazil
    BRE Wins Final Permit to Advance Rare Earth Pilot Plant in Brazil
    • News

  • Harris Technology eyes profitability as refurbished tech sales surge
    Harris Technology eyes profitability as refurbished tech sales surge
    • News

  • QIC Fund Backs Ark Mines with $4.5m to Accelerate Sandy Mitchell Development
    • News

  • Swift Secures $2.4m Chevron Contract to Extend Entertainment and Support Services
    Swift Secures $2.4m Chevron Contract to Extend Entertainment and Support Services
    • News

  • FBR’s tech could help reduce housing construction-related cost pressures
    FBR’s tech could help reduce housing construction-related cost pressures
    • News

  • Atomo Locks in US$410K Pascal Order as FebriDx Demand Accelerates in the US
    Atomo Locks in US$410K Pascal Order as FebriDx Demand Accelerates in the US
    • News

Healthia R&D Hub secures $810k grant for 3D digital solutions to treat diabetes-related foot ulcers

  • In News
  • March 21, 2023
  • Alfred Chan
Healthia R&D Hub secures $810k grant for 3D digital solutions to treat diabetes-related foot ulcers

Healthia (ASX: HLA) may be best known for operating more than 300 allied health clinics across Australia and New Zealand, but the rising allied health company continues to be at the forefront of medical research. Together with a team of researchers from the Queensland University of Technology, James Cook University and Healthia’s R&D Hub, they were awarded a $810k grant to develop 3D digital solutions for diabetes related foot ulcer treatments.

The grant is part of the Australian Government’s Medical Research Future Fund (MRFF) which, last week, announced more than $382 million in grants, including more than $32 million to improve First Nations health.

For Healthia, the recent launch of their R&D Hub is an extension of the work driven by Chief Technology Officer, Dean Hartley. Prior to his role as CTO, Hartley founded iOrthotics which is the largest manufacturer of 3D printed orthotics in Australia. iOrthotics was then acquired by Healthia as part of their IPO in 2018.

“Scott Morrison (General Manager, iOrthotics), Dr Kerrie Evans (Healthia’s Chief Group Education & Research Officer and Senior Research Fellow at The University of Sydney) and I are excited to share we are part of a team that have received a MRFF grant to explore 3D digital solutions for diabetes related foot ulcer offloading treatment,” said Hartley.

“Together with researchers from Queensland University of Technology and James Cook University, Dr Kerrie Evans is a Chief Investigator and iOrthotics Associate Investigators on the grant that aims to deliver better access to people living in regional, rural and remote communities via developing and translating digital diagnostic, monitoring, and treatment technologies.”

The grant continues excellent work being conducted at the Healthia R&D Hub which last year secured a $2.1 million Cooperative Research Centre Project (CRC-P) grant to develop smart orthotics that could assist communities. The tech-enabled smart orthotics evaluate whether using advanced scanning and smart orthotic technology could improve health service delivery and patient health outcomes.

Foot ulcers remain one of the most significant complications for people with diabetes resulting in more than 4,400 amputations every year. Australians spend $14.6 billion annually on diabetes management and treatment.

By integrating technology into 3D printed orthotics, Healthia researchers aim to tackle growing chronic health conditions in rural Australia where alerts can be generated to seek medical attention prior to worsening conditions that could lead to amputation.

This latest round of medical research grants is part of the Labor Government’s commitment to improve healthcare within indigenous communities.

Minister for Health and Aged Care, Mark Butler said, “This funding is about strengthening opportunities for Australian health and medical research. It will help commercialise proof-of-concepts, and deepen international research ties now and in the future.”

“As the Albanese Government renews the focus on Closing the Gap, it is timely that significant research funding will address health issues that are important to the health of our First Nations people.”

The Healthia R&D Hub is one of the newer divisions within Healthia which is the largest provider of podiatry services in Australia. Clinics are supplied with 3D printed orthotics which Healthia clinicians can prescribe following a digital foot scan before iOrthotics produces the custom orthotic devices with near-zero waste, more accurately and significantly quicker than hand-manufactured devices.

In addition to supplying Healthia’s podiatry clinics and hundreds of other clinics around Australasia, iOrthotics is also active in North America where they produce the 3D printed orthotics from their facility in New York.

The Healthia R&D Hub now boasts partnerships with Queensland University of Technology, The University of Queensland, ARC Research Hub for Advanced Manufacturing of Medical Devices, North West Hospital and Health Service, Advanced Manufacturing Growth Centre and My FootDr.

  • About
  • Latest Posts
Alfred Chan
Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.
Latest posts by Alfred Chan (see all)
  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians - April 30, 2025
  • Harris Technology secures major investment from Taiwan’s FSP Technology at 100% premium - March 10, 2025
  • ARC Funds acquires 30% of auzbiz Capital as latest direct-to-investor marketing venture - October 8, 2024
*Owners of this website are shareholders in a company mentioned in this article and have been engaged by them to assist in investor communications
  •  
  •  
  •  
  •  
  • asx hla
  • dean hartley
  • healthia
  • HLA
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Alfred Chan
Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.
Latest posts by Alfred Chan (see all)
  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians - April 30, 2025
  • Harris Technology secures major investment from Taiwan’s FSP Technology at 100% premium - March 10, 2025
  • ARC Funds acquires 30% of auzbiz Capital as latest direct-to-investor marketing venture - October 8, 2024

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Alfred Chan
Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.
Latest posts by Alfred Chan (see all)
  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians - April 30, 2025
  • Harris Technology secures major investment from Taiwan’s FSP Technology at 100% premium - March 10, 2025
  • ARC Funds acquires 30% of auzbiz Capital as latest direct-to-investor marketing venture - October 8, 2024
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.